Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: Commodity, Ex-Dividend Stocks Weigh On FTSE 100

Thu, 18th Feb 2016 17:05

LONDON (Alliance News) - Shares in the London ended mixed Thursday, with commodity stocks and several hefty constituents going ex-dividend weighing on the FTSE 100, amid a flurry of economic data from China, Europe and the US.

The FTSE 100 ended down 1.0% at 5,971.95 points, ending in the red for the first time this week after a strong run in the past four sessions. The FTSE 250 closed up 0.1% at 16,176.75 and the AIM All-Share up 0.7% at 682.54.

In Europe the CAC 40 in Paris ended up 0.2% and the DAX 30 in Frankfurt closed up 0.9%.

Stocks in New York were lower at the London close, with the Dow Jones Industrial Average down 0.2%, the S&P 500 down 0.3% and the Nasdaq Composite down 0.6%.

First-time claims for US unemployment benefits unexpectedly decreased in the week ended February 14, according to a report released by the US Labor Department. The report said initial jobless claims fell to 262,000 from 269,000 the prior week, the lowest level since the week ended November 22. The drop surprised economists, who had expected jobless claims to rise to 275,000.

The report said continuing claims, a reading on the number of people receiving ongoing unemployment assistance, rose by 30,000 to 2.273 million in the week ended February 7.

The US Conference Board released a report showing a modest decrease by its index of leading US economic indicators in January, driven primarily by steep drops in stock prices and weakness in initial jobless claims. The Conference Board said its leading economic index declined by 0.2% in January following a revised 0.3% decrease in December. The modest drop by the index matched economist estimates.

Meanwhile, a report from the Federal Reserve Bank of Philadelphia revealed a modest increase by its index of regional manufacturing activity in February, but the index remained negative for the sixth consecutive month. The Philadelphia Fed said the diffusion index for current activity rose to a negative 2.8 in February from a negative 3.5 in January. A negative reading indicates continued weakness in business conditions. Economists had expected the index to inch up to a negative 3.0.

At the London close, the pound was slightly higher against the dollar. Sterling was quoted at USD1.4331, having stood at USD1.4328 at the close on Wednesday.

The euro was at USD1.1088 at the close, versus USD1.1133 at the close Wednesday.

The European Central Bank warned about "increased downside risks" in the minutes from its monetary policy meeting held January 21, released Thursday.

"Downside risks had increased again since the beginning of the current year, amid heightened uncertainty about the growth prospects of emerging market economies, volatility in financial markets and geopolitical risks," the minutes said.

The ECB minutes said that inflation had continued to be weaker-than-expected, mainly due to the renewed sharp fall in oil prices and the persistently subdued underlying price pressures.

Financial market conditions in the euro area had clearly deteriorated since the early December Governing Council meeting, although the magnitude and persistence of these developments were still uncertain, the report added.

The minutes also said that there was unanimity in the Governing Council in seeking a review of the policy stance in the next meeting on March 10 after a thorough analysis of data and also after receiving the latest ECB Staff macroeconomic projections.

Timo del Carpio, European Economist at RBC Capital markets said he saw little in the minutes that alters the more recent messages from various ECB officials.

"Looking ahead to March 10, a lively discussion on the macroeconomic outlook should again be expected. But with new staff projections and a firm commitment from the Governing Council to reconsider its stance, the Governing Council will have little excuse not to deliver a judgement on the appropriate policy stance the next time around," Del Carpio said.

Meanwhile, data from the ECB showed that the euro area current account surplus declined in December as the surplus on trade in goods and services dropped from the prior month. The current account surplus fell to EUR25.5 billion from EUR26.9 billion in November. The surplus on trade in goods dropped to EUR26.5 billion from EUR27.5 billion and that on services fell to EUR4.6 billion from EUR6 billion a month ago.

In Asia on Thursday, the Japanese Nikkei 225 index closed up 2.3%. The Shanghai Composite ended down 0.2% but the Hang Seng index in Hong Kong closed up 2.3%.

China's inflation accelerated to a five-month high in January, and the producer price index declined at a slower pace, data from the National Bureau of Statistics revealed.

Consumer prices advanced 1.8% year-on-year in January, faster than December's 1.6% increase. This was the highest rate since August 2015, when inflation was 2%, but slightly slower than the 1.9% rise forecast by economists. Producer prices dropped 5.3%, slower than the 5.9% decline seen in December. Prices were expected to fall 5.4%.

Data from the US Energy Information Administration showed that crude stockpiles in the US rose in the week ended February 12. The report said US crude oil inventories soared by 2.14 million barrels last week, compared to the decline of 754,000 barrels from the prior week. Economists expected an increase of 3.92 million barrels.

Following the data, North Sea benchmark Brent oil price dropped substantially, standing at USD34.34 a barrel at the London close, compared to USD35.34 prior. US benchmark West Texas Intermediate was also hit, falling to USD30.87 at the close versus USD31.65 before the data.

BP ended down 1.5%, while in the FTSE 250 Petrofac and Wood Group dropped 5.0% and 2.1%, respectively.

Meanwhile, shares in Tullow Oil ended at the bottom of the FTSE 250, down 11%. The oil and gas company said it has implemented extra "operational procedures" on the floating production, storage and offloading vessel serving the Jubilee field offshore Ghana after identifying an potential issue in the turret area.

Tullow said an inspection of the turret area of the FPSO was carried out by SOFEC, the original manufacturer of the turret, which identified "a potential issue" with the turret bearing.

Royal Dutch 'A' and 'B' shares ended down 3.2% and 2.2%, respectively, having gone ex-dividend alongside pharmaceutical giants GlaxoSmithKline, down 3.3%, and AstraZeneca, down 3.8%.

Shares in FTSE 100-listed mining companies were also sold, giving back some of their gains from Wednesday, with Anglo American down 4.7%, Rio Tinto down 3.1% and Glencore down 1.2%.

Gold was quoted at USD1,217.39 at the London close, adding to its impressive rally since the start of 2016.

At the other end of the index, gas distributor and producer Centrica led the blue-chip gainers, up 3.6%, after it reported full-year results that significantly beat expectations, as the drag on earnings from its upstream unit was not as bad as expected. Centrica reported a 4% fall in net earnings to GBP863.0 million in 2015 from GBP903.0 million in 2014, but the figure was significantly higher than analyst expectations of GBP733.0 million.

Adjusted operating cashflow, which Centrica said would be a "major focus" back in December, came in ahead of the group's guidance at GBP2.25 billion, which was also up 2% from GBP2.20 billion last year. Revenue for 2015 fell 5% to GBP28.00 billion. Centrica will pay a dividend for the year of 12.0 pence per share, down from 13.5 pence in 2014.

Following the results, Jefferies reiterated its Buy rating on Centrica, saying that the full-year results suggest the group's cash flow will remain strong in the current low commodity price environment.

BAE Systems also ended in the green, up 1.7%. The defence contractor provided a brighter outlook for 2016, as had been expected, indicating trading conditions for the group are starting to improve following years of squeezed defence budgets globally.

The defence contractor said its underlying earnings per share in 2016 should be around 5% to 10% higher than in 2015, helped by defence budgets increasing around the world and by growing sales in its cyber security and international sales, the latter of which should be boosted by higher Typhoon support service contract revenue.

This will offset declines in the US and UK, with the US set to see a reduction in naval ship repair activity, while UK sales will fall due to lower planned Typhoon deliveries, though higher submarine programme activity should help to offset falling aircraft carrier sales.

Drugmaker Indivior closed up 16%, making it the best FTSE 250 performer, as investors welcomed full year results from the group, which beat its previously lifted guidance, despite profit about halving in 2015 and the company saying it does not plan to pay further dividends in the "forseeable future".

Indivior has seen a better-than-expected first year as a public company following its spin-out from consumer goods giant Reckitt Benckiser Group in late 2014, despite the higher costs of operating on a standalone basis and increasing generic competition to its key product, Suboxone Film.

Indivior said its pretax profit for the year to the end of December was USD285.0 million, down from USD561.0 million a year earlier. It will pay a final dividend of 9.5 cents per share, taking its total dividend to 12.7 cents.

Transport company Go-Ahead Group closed up 6.0% after it said its first-half results met its expectations and affirmed its outlook for the full year as it saw solid performances in its bus and rail divisions. Pretax profit for the half-year to December 26 was GBP52.1 million, up from GBP44.7 million a year earlier, helped by a big rise in profit from its rail division. Go-Ahead will pay an interim dividend of 28.33 pence per share, up from 26.60p a year earlier.

Shore Capital upgraded the stock to Buy from Hold. The broker noted the company's shares have fallen by 16% year-to-date, giving them an attractive set of multiple and yield metrics.

In the corporate calendar, Coca-Cola HBC, Standard Life, M&C Saatchi, Segro, Essentra and Millennium & Copthorne Hotels release full-year results.

In the economic calendar Friday, Japan's All Industry Activity Index is due at 0330 GMT, while Germany's Producer Price Index is due at 0700 GMT. UK's Retail Sales data are at 0930 GMT, at the same time as UK Public Sector Net Borrowing data. The UK CB Leading economic index is due at 1430 GMT, while eurozone's consumer confidence is at 1500 GMT. In the US, inflation data are due at 1330 GMT.

By Daniel Ruiz; danielruiz@alliancenews.com

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
22 Nov 2023 09:48

LONDON BROKER RATINGS: RBC cuts HSBC; Liberum cuts Glencore

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
21 Nov 2023 11:52

GSK to begin phase 3 trials of low-carbon Ventolin inhaler in 2024

(Alliance News) - GSK PLC on Tuesday said it will begin phase 3 trials of a low carbon version of its metered dose inhaler Ventolin using a "next generation" propellant in 2024.

Read more
14 Nov 2023 17:04

LONDON MARKET CLOSE: FTSE 100 underwhelms as stocks jump after US CPI

(Alliance News) - European equities jumped in the wake of a cooler-than-expected US inflation reading, which took some sting out of a recent hawkish reassessment of the Federal Reserve interest rate outlook.

Read more
13 Nov 2023 09:47

GSK hails momelotinib opinion from European Medicines Agency committee

(Alliance News) - GSK PLC on Monday announced that a European Medicines Agency panel has given a positive opinion recommending momelotinib to treat myelofibrosis patients with anaemia.

Read more
9 Nov 2023 15:50

UK dividends calendar - next 7 days

Friday 10 November 
Bodycote PLCdividend payment date
Breedon Group PLCdividend payment date
Chesnara PLCdividend payment date
Finsbury Growth & Income Trust PLCdividend payment date
Invesco Bond Income Plus Ltddividend payment date
JPMorgan Emerging Markets Investment Trust PLCdividend payment date
Kerry Group PLCdividend payment date
Merchants Trust PLCdividend payment date
Mid Wynd International Investment Trust PLCdividend payment date
Mid Wynd International Investment Trust PLCspecial dividend payment date
Montanaro UK Smaller Cos Investment Trust PLCdividend payment date
Senior PLCdividend payment date
Spectris PLCdividend payment date
Spirax-Sarco Engineering PLCdividend payment date
Travis Perkins PLCdividend payment date
Monday 13 November 
no events scheduled 
Tuesday 14 November 
no events scheduled 
Wednesday 15 November 
Coats Group PLCdividend payment date
Ferguson PLCdividend payment date
JP Morgan Mid Cap Investment Trust PLCdividend payment date
Strategic Equity Capital PLCdividend payment date
Thursday 16 November 
abrdn Property Income Trust Ltdex-dividend payment date
Asian Energy Impact Trust PLCex-dividend payment date
Baillie Gifford Japan Trust PLCex-dividend payment date
BlackRock Greater Europe Investment Trust PLCex-dividend payment date
Bunzl PLCex-dividend payment date
Bytes Technology Group PLCex-dividend payment date
Centrica PLCdividend payment date
Coca-Cola Europacific Partners PLCex-dividend payment date
DX Group PLCex-dividend payment date
Empiric Student Property PLCex-dividend payment date
Fonix Mobile PLCex-dividend payment date
GCP Asset Backed Income Fund Ltdex-dividend payment date
GSK PLCex-dividend payment date
Hargreaves Lansdown PLCex-dividend payment date
Henderson Opportunities Trust PLCex-dividend payment date
ICG Enterprise Trust PLCex-dividend payment date
James Halstead PLCex-dividend payment date
Lancashire Holdings Ltdspecial ex-dividend payment date
Majedie Investments PLCex-dividend payment date
Marks & Spencer Group PLCex-dividend payment date
Murray Income Trust PLCex-dividend payment date
New Star Investment Trust PLCex-dividend payment date
NextEnergy Solar Fund Ltdex-dividend payment date
Octopus Renewables Infrastructure Trust PLCex-dividend payment date
Pershing Square Holdings Ltdex-dividend payment date
Personal Group Holdings PLCdividend payment date
Redrow PLCdividend payment date
Regional REIT Ltdex-dividend payment date
Schroder Oriental Income Fund Ltdex-dividend payment date
Scottish American Investment Co PLCex-dividend payment date
SCS Group PLCex-dividend payment date
Shell PLCex-dividend payment date
Supermarket Income REIT PLCdividend payment date
UK Commercial Property REIT Ltdex-dividend payment date
Unilever PLCex-dividend payment date
Wincanton PLCex-dividend payment date
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
8 Nov 2023 09:30

LONDON BROKER RATINGS: UBS downbeat on AJ Bell and Hargreaves Lansdown

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
2 Nov 2023 10:14

LONDON BROKER RATINGS: Bank of America starts Unite Group with 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 Nov 2023 16:52

LONDON MARKET CLOSE: Stocks prosper ahead of central bank rate calls

(Alliance News) - Stocks in London took their lead from a positive start on Wall Street to close higher as investors prepare for interest rate decisions in the UK and US.

Read more
1 Nov 2023 16:35

London close: Stocks rise ahead of US Fed policy decision

(Sharecast News) - London's stock market finished in positive territory on Wednesday, with investors keeping a keen eye on the upcoming policy announcement from the US Federal Reserve.

Read more
1 Nov 2023 08:51

TOP NEWS: GSK ups guidance as boosted by Shingrix and Arexvy

(Alliance News) - GSK PLC on Wednesday hailed the performance of the world's first approved respiratory syncytial virus vaccine Arexvy, as it reported a rise in profit and revenue.

Read more
1 Nov 2023 08:50

LONDON MARKET OPEN: FTSE 100 up, FTSE 250 down as Aston Martin tumbles

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of key central bank decisions, as investors were cheered by some strong updates from large-cap listings.

Read more
1 Nov 2023 07:40

LONDON BRIEFING: GSK raises annual guidance following Arexvy launch

(Alliance News) - Stocks in London are called higher on Wednesday, with the main focal point for the day being the upcoming US interest rate decision.

Read more
1 Nov 2023 07:27

GSK hikes guidance after strong third quarter

(Sharecast News) - GSK announced a robust third quarter on Wednesday, prompting an upgrade to its full-year guidance.

Read more
30 Oct 2023 09:01

IN BRIEF: GSK says Jemperli meets endpoint in endometrial cancer trial

GSK PLC - Brentford, west London-based pharmaceutical maker - Jemperli, whose generic name is dostarlimab, meets endpoint of overall survival in phase III Ruby trial on adult patients with primary advanced or recurrent endometrial cancer. Jemperli, combined with standard-of-care chemotherapy, followed by dostarlimab, demonstrated a "statistically significant and clinically meaningful benefit" to the patients in the trial.

Read more
30 Oct 2023 07:06

GSK's Jemperli sees success in endometrial cancer trial

(Sharecast News) - GSK reported encouraging outcomes from part one of the 'RUBY' phase three trial evaluating the efficacy of 'Jemperli', or dostarlimab, with standard chemotherapy for treating adult patients with advanced or recurrent endometrial cancer on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.